These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 15286381)

  • 1. Protein kinase A and signal transduction in T lymphocytes: biochemical and molecular methods.
    Khan IU; Kammer GM
    Methods Mol Med; 2004; 102():73-85. PubMed ID: 15286381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficient type I protein kinase A isozyme activity in systemic lupus erythematosus T lymphocytes: II. Abnormal isozyme kinetics.
    Kammer GM; Khan IU; Kammer JA; Olorenshaw I; Mathis D
    J Immunol; 1996 Sep; 157(6):2690-8. PubMed ID: 8805675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of deficient type I protein kinase A activity in lupus T lymphocytes.
    Kammer GM; Laxminarayana D; Khan IU
    Int Rev Immunol; 2004; 23(3-4):225-44. PubMed ID: 15204086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diminished levels of protein kinase A RI alpha and RI beta transcripts and proteins in systemic lupus erythematosus T lymphocytes.
    Laxminarayana D; Khan IU; Mishra N; Olorenshaw I; Taskén K; Kammer GM
    J Immunol; 1999 May; 162(9):5639-48. PubMed ID: 10228048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isozymes of cyclic AMP-dependent protein kinases (PKA) in human lymphoid cell lines: levels of endogenous cAMP influence levels of PKA subunits and growth in lymphoid cell lines.
    Skålhegg BS; Johansen AK; Levy FO; Andersson KB; Aandahl EM; Blomhoff HK; Hansson V; Taskén K
    J Cell Physiol; 1998 Oct; 177(1):85-93. PubMed ID: 9731748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficient protein kinase a in systemic lupus erythematosus: a disorder of T lymphocyte signal transduction.
    Kammer GM
    Ann N Y Acad Sci; 2002 Jun; 968():96-105. PubMed ID: 12119270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficient type I protein kinase A isozyme activity in systemic lupus erythematosus T lymphocytes.
    Kammer GM; Khan IU; Malemud CJ
    J Clin Invest; 1994 Jul; 94(1):422-30. PubMed ID: 8040283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of deficient type II protein kinase A activity with aberrant nuclear translocation of the RII beta subunit in systemic lupus erythematosus T lymphocytes.
    Mishra N; Khan IU; Tsokos GC; Kammer GM
    J Immunol; 2000 Sep; 165(5):2830-40. PubMed ID: 10946316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of T cell type I protein kinase A deficiency in systemic lupus erythematosus.
    Kammer GM
    Arthritis Rheum; 1999 Jul; 42(7):1458-65. PubMed ID: 10403274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TCR zeta-chain abnormalities in human systemic lupus erythematosus.
    Nambiar MP; Krishnan S; Warke VG; Tsokos GC
    Methods Mol Med; 2004; 102():49-72. PubMed ID: 15286380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of novel PKA holoenzymes in human T lymphocytes.
    Orstavik S; Funderud A; Hafte TT; Eikvar S; Jahnsen T; Skålhegg BS
    FEBS J; 2005 Apr; 272(7):1559-67. PubMed ID: 15794744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase A RI beta subunit deficiency in lupus T lymphocytes: bypassing a block in RI beta translation reconstitutes protein kinase A activity and augments IL-2 production.
    Khan IU; Laxminarayana D; Kammer GM
    J Immunol; 2001 Jun; 166(12):7600-5. PubMed ID: 11390516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mRNA mutations of type I protein kinase A regulatory subunit alpha in T lymphocytes of a subject with systemic lupus erythematosus.
    Laxminarayana D; Kammer GM
    Int Immunol; 2000 Nov; 12(11):1521-9. PubMed ID: 11058571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell signaling abnormalities in human systemic lupus erythematosus.
    Nambiar MP; Krishnan S; Tsokos GC
    Methods Mol Med; 2004; 102():31-47. PubMed ID: 15286379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cytokine production and cytotoxic activity of human antimelanoma specific CD8+ and CD4+ T lymphocytes by adenosine-protein kinase A type I signaling.
    Raskovalova T; Lokshin A; Huang X; Su Y; Mandic M; Zarour HM; Jackson EK; Gorelik E
    Cancer Res; 2007 Jun; 67(12):5949-56. PubMed ID: 17575165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attempt to correct abnormal signal transduction in T lymphocytes from systemic lupus erythematosus patients.
    Fujii Y; Fujii K; Tanaka Y
    Autoimmun Rev; 2006 Feb; 5(2):143-4. PubMed ID: 16431347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel, isotype-specific sensors for protein kinase A subunit interaction based on bioluminescence resonance energy transfer (BRET).
    Prinz A; Diskar M; Erlbruch A; Herberg FW
    Cell Signal; 2006 Oct; 18(10):1616-25. PubMed ID: 16524697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. beta-Agonist enhances type 2 T-cell survival and accumulation.
    Loza MJ; Peters SP; Foster S; Khan IU; Penn RB
    J Allergy Clin Immunol; 2007 Jan; 119(1):235-44. PubMed ID: 17208607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Abnormal signaling activity of phosphatidylinositol 3-kinase pathway in peripheral blood T cells from patients with systemic lupus erythematosus].
    Liang LQ; Zhan ZP; Xu HS; Yang XY; Ye YJ; Lian F; Qiu Q
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(29):2036-40. PubMed ID: 19080430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphoinositide-dependent kinase 1 targets protein kinase A in a pathway that regulates interleukin 4.
    Nirula A; Ho M; Phee H; Roose J; Weiss A
    J Exp Med; 2006 Jul; 203(7):1733-44. PubMed ID: 16785309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.